QuatRx Pharmaceuticals Initiates Phase I Trial For Treatment To Reduce Both LDL Cholesterol And Lipoprotein (A)

... QuatRx Pharmaceuticals, a privately held biopharmaceutical company focused on research and development of therapeutic compounds for the treatment of major endocrine, metabolic and cardiovascular diseases, today announced that it has initiated a Phase I clinical study of QRX-431, a novel compound in development for the treatment of elevated cholesterol levels and obesity. [click link for full article] ...